Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.07 -0.06 (-1.45%)
As of: Oct 1, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Non-Current Deffered Revenue (2020 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) reported Non-Current Deffered Revenue of $112.82 million for Q2 2026, down 10.6% from $126.24 million a year earlier and down 1.7% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends

At the end of FY2025, Recursion Pharmaceuticals posted Non-Current Deffered Revenue of $114.01 million, down 4.0% from FY2024.

  • Non-Current Deffered Revenue has a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
  • By year, Non-Current Deffered Revenue came in at $118.77 million in FY2024 (+131.8%), $51.24 million in FY2023 (-27.1%), $70.26 million in FY2022 (+953.9%) and $6.67 million in FY2021 (-60.0%).
  • Five-year quarterly Non-Current Deffered Revenue spans a low of $6.67 million in Q4 2021 and a high of $129.61 million in Q1 2025.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last three quarters, with growth averaging 152.9% over the last eight quarters.
  • The high point for year-over-year Non-Current Deffered Revenue in five years was Q4 2022 (growth of 953.9%); the low point was Q3 2024 (a decline of 69.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $114.72 million (Q1 2026), $114.01 million (Q4 2025) and $111.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Recursion Pharmaceuticals 2.21 Bn -397.37 Mn -3.82 Mn 112.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 112.82 Mn
Mar 31, 2026 114.72 Mn
Dec 31, 2025 114.01 Mn
Sep 30, 2025 111.20 Mn
Jun 30, 2025 126.24 Mn
Mar 31, 2025 129.61 Mn
Dec 31, 2024 118.77 Mn
Sep 30, 2024 15.71 Mn
Jun 30, 2024 29.17 Mn
Mar 31, 2024 37.39 Mn
Dec 31, 2023 51.24 Mn
Sep 30, 2023 51.38 Mn
Jun 30, 2023 32.44 Mn
Mar 31, 2023 57.09 Mn
Dec 31, 2022 70.26 Mn
Sep 30, 2022 93.91 Mn
Jun 30, 2022 89.93 Mn
Mar 31, 2022 107.12 Mn
Dec 31, 2021 6.67 Mn
Sep 30, 2021 9.17 Mn
API Access

Recursion Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RXRX&period=max&api_key=YOUR_API_KEY